Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma

AKTEPE, OKTAY; GÜNER, GÜRKAN; GÜVEN, DENİZ; TABAN, HAKAN; YILDIRIM, HASAN; ŞAHİN, TAHA; Ardic, Fadime; Yeter, HACI; YÜCE, DENİZ; ERMAN, MUSTAFA

doi:10.5152/tud.2021.20377

Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma

AKTEPE O. H., GÜNER G., GÜVEN D. C., TABAN H., YILDIRIM H. Ç., ŞAHİN T. K., ...Daha Fazla

TURKISH JOURNAL OF UROLOGY, cilt.47, sa.2, ss.113-119, 2021 (ESCI, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 47 Sayı: 2
Basım Tarihi: 2021
Doi Numarası: 10.5152/tud.2021.20377
Dergi Adı: TURKISH JOURNAL OF UROLOGY
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.113-119
Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: The albumin to globulin ratio (AGR) has been demonstrated to be associated with survival outcomes in various tumor types. However, the prognostic value of AGR in patients with metastatic renal carcinoma (mRCC) remains unclear. Therefore, this study aimed to investigate the impact of AGR values in predicting overall survival (OS) of patients with mRCC treated with targeted therapy.